NEW YORK: Ketchum has won a PR brief for Novartis'
yet-to-be-branded arthritis treatment. The agency beat Hill & Knowlton
and Chamberlain Communications Group for the account to handle all
communications in the US for the COX189 through the drug's launch. The
drug is expected to become available in 2003.
